Getinge Stock

Getinge Equity 2024

Getinge Equity

30.17 B SEK

Ticker

GETI B.ST

ISIN

SE0000202624

WKN

889714

In 2024, Getinge's equity was 30.17 B SEK, a 0.43% increase from the 30.04 B SEK equity in the previous year.

Getinge Aktienanalyse

What does Getinge do?

Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Getinge's Equity

Getinge's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Getinge's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Getinge's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Getinge's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Getinge’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Getinge stock

What is the equity of Getinge this year?

Getinge has equity of 30.17 B SEK this year.

What was the equity of Getinge compared to the previous year?

The equity of Getinge has increased/decreased by 0.43% increased compared to the previous year.

What impact does a high equity have on investors of Getinge?

A high equity is advantageous for investors of Getinge as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Getinge?

A low equity can be a risk for investors of Getinge, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Getinge affect the company?

An increase in equity of Getinge can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Getinge affect the company?

A reduction in equity of Getinge can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Getinge?

Some factors that can affect the equity of Getinge include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Getinge so important for investors?

The equity of Getinge is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Getinge take to change the equity?

To change equity, Getinge can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Getinge pay?

Over the past 12 months, Getinge paid a dividend of 4.25 SEK . This corresponds to a dividend yield of about 1.97 %. For the coming 12 months, Getinge is expected to pay a dividend of 4.48 SEK.

What is the dividend yield of Getinge?

The current dividend yield of Getinge is 1.97 %.

When does Getinge pay dividends?

Getinge pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Getinge?

Getinge paid dividends every year for the past 14 years.

What is the dividend of Getinge?

For the upcoming 12 months, dividends amounting to 4.48 SEK are expected. This corresponds to a dividend yield of 2.08 %.

In which sector is Getinge located?

Getinge is assigned to the 'Health' sector.

Wann musste ich die Aktien von Getinge kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Getinge from 4/29/2024 amounting to 4.4 SEK, you needed to have the stock in your portfolio before the ex-date on 4/23/2024.

When did Getinge pay the last dividend?

The last dividend was paid out on 4/29/2024.

What was the dividend of Getinge in the year 2023?

In the year 2023, Getinge distributed 4 SEK as dividends.

In which currency does Getinge pay out the dividend?

The dividends of Getinge are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Getinge

Our stock analysis for Getinge Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Getinge Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.